Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

309.19B

Market cap309.19B

Price-Earnings ratio

21.02

Price-Earnings ratio21.02

Dividend yield

1.66%

Dividend yield1.66%

Average volume

6.75M

Average volume6.75M

High today

$70.77

High today$70.77

Low today

$68.53

Low today$68.53

Open price

$69.73

Open price$69.73

Volume

6.52M

Volume6.52M

52 Week high

$143.49

52 Week high$143.49

52 Week low

$57.00

52 Week low$57.00

NVO News

TipRanks 17h

Novo Nordisk’s IcoSema Study: A New Frontier in Diabetes Treatment?

Novo Nordisk ((DE:NOVA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!...

TipRanks 17h

Novo Nordisk’s Diabetes Study: A Potential Game-Changer?

Novo Nordisk ((DE:NOVA)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% of...

Sherwood News 3d

Hims jumps after announcing plans to offer generic Wegovy in Canada in 2026

Hims jumps after announcing plans to offer generic Wegovy in Canada in 2026 Hims & Hers rose after the company announced that it will expand to Canada next yea...

Analyst ratings

63%

of 32 ratings

Buy

62.5%

Hold

28.1%

Sell

9.4%

More NVO News

CNBC 3d

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Hims & Hers Health announced Wednesday it will offer generic semaglutide in...

Sherwood News 4d

Eli Lilly is fattening its stockpiles of GLP-1s to prevent tariffs from trimming its profits

Imports of peptides and protein-based hormones — the category that GLP-1 weight-loss drugs fall under — from Ireland are already more than double than last year...

Benzinga 4d

Does Higher Dose Of Wegovy Result In More Weight Loss? Novo Nordisk Seeks European Approval

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its...

Seeking Alpha 4d

Novo Nordisk submits new Wegovy dose for EU approval

Novo Nordisk (NVO) announced on Tuesday that it has submitted a new higher dose of its weight loss medication, Wegovy, to the European Medicines Agency for appr...

Benzinga 5d

Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 1...